Kobayashi Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kobayashi Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 119.48 billion Japanese Yen [US$1.04 billion]
of which 99%
was Pharmaceutical Business),
Sawai Pharmaceutical Co., Ltd.
(123.49 billion Japanese Yen [US$1.08 billion]
of which 100%
was Pharmaceutical Business), and
Nichi-Iko Pharmaceutical Company Limited
(143.51 billion Japanese Yen [US$1.25 billion]
of which 100%
was Ethical Pharmaceutical).
Kobayashi Pharmaceutical Co Ltd reported sales of ¥137.21 billion (US$1.20 billion)
March of 2016.
increase of 6.9%
versus 2015, when the company's sales were ¥128.34 billion.
This was the third consecutive year of growth at Kobayashi Pharmaceutical Co Ltd.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Kobayashi Pharmaceutical Co Ltd had sales
of ¥130.82 billion.
Sales of Other Businesses saw an increase
that was more than double the company's growth rate: sales were up
151.0% in 2016, from
¥1.08 billion to ¥2.71 billion.
Not all segments of Kobayashi Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Mail Order fell 4.9% to ¥8.54 billion.